- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03444233
Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.
February 16, 2018 updated by: University of Hohenheim
The purpose of this study is to investigate how a high-fructose diet, either by high fructose intake from complex, natural foods or by fortifying the diet with corn syrup, affects the metabolism.
Furthermore, it will be investigate if there are differences between obese and normal weight participants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Healthy adults, aged between 20 and 30 years
- normal weighted (BMI ≤ 25 kg/m2) and obese (BMI 35-50 kg/m2)
- written informed consent
At initial medical examination an anamnesis, physical examination, blood sample collection (10 ml) was performed to check for eligibility. Furthermore, a hydrogen breath test was performed to detect potential fructose intolerance
Exclusion Criteria:
- smoking,
- fructose intolerance/ -malabsorption,
- pregnancy
- chronic gastrointestinal diseases (e.g. chronic inflammatory bowel disease, irritable bowel syndrome, celiac disease etc.),
- operation on the gastrointestinal tract (exclusively appendectomy)
- anemia,
- hepatic or renal disease
- diabetes mellitus
- consuming illnesses (e.g. cancer, acquired immunodeficiency syndrome (AIDS)) - drug intake affecting lipid or glucose metabolism (cholesterol- or glucose reducing or antihypertensive drugs, steroids, L-Thyroxin, antidepressants, weight reducing drugs).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low f1 diet
low fructose diet week 1
|
7 days fruit-rich diet, 7 days HFCS-rich diet
Other Names:
|
Experimental: fruit rich diet
fruit rich diet week 2
|
7 days fruit-rich diet, 7 days HFCS-rich diet
Other Names:
|
Experimental: low f2 diet
low fructose diet week 3
|
7 days fruit-rich diet, 7 days HFCS-rich diet
Other Names:
|
Experimental: HFCS rich diet
HFCS rich diet week 4
|
7 days fruit-rich diet, 7 days HFCS-rich diet
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
metabolite concentration
Time Frame: Participants will be followed for the time of four weeks.
|
The primary endpoint is the change of metabolite concentration after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fatty liver index
Time Frame: Participants will be followed for the time of four weeks.
|
Change in fatty liver index after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Non-alcoholic fatty liver disease (NAFLD)
Time Frame: Participants will be followed for the time of four weeks.
|
Change in the classification of non-alcoholic fatty liver disease (NAFLD) based on ultrasound after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Body weight
Time Frame: Participants will be followed for the time of four weeks.
|
Change from baseline in body weight after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Blood pressure (systolic and diastolic)
Time Frame: Participants will be followed for the time of four weeks.
|
Change in blood pressure (systolic and diastolic) after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
GGT
Time Frame: Participants will be followed for the time of four weeks.
|
Change in GGT after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
GOT
Time Frame: Participants will be followed for the time of four weeks.
|
Change in GOT after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
GPT
Time Frame: Participants will be followed for the time of four weeks.
|
Change in GPT after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
AP
Time Frame: Participants will be followed for the time of four weeks.
|
Change in AP after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Triglycerides
Time Frame: Participants will be followed for the time of four weeks.
|
Change in triglycerides after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
HDL
Time Frame: Participants will be followed for the time of four weeks.
|
Change in HDL after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
LDL
Time Frame: Participants will be followed for the time of four weeks.
|
Change in LDL after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Fasting glucose
Time Frame: Participants will be followed for the time of four weeks.
|
Change in fasting glucose after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
BSR
Time Frame: Participants will be followed for the time of four weeks.
|
Change in BSR after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Kreatinine
Time Frame: Participants will be followed for the time of four weeks.
|
Change in Kreatinine after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Uric acid
Time Frame: Participants will be followed for the time of four weeks.
|
Change in uric acid after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Urea
Time Frame: Participants will be followed for the time of four weeks.
|
Change in urea after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Cholesterol
Time Frame: Participants will be followed for the time of four weeks.
|
Change in cholesterol after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Ghrelin
Time Frame: Participants will be followed for the time of four weeks.
|
Change in ghrelin after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Leptin
Time Frame: Participants will be followed for the time of four weeks.
|
Change in leptin after low fructose diet week 1, fruit rich diet, low fructose diet week 3 and HFCS rich diet.
|
Participants will be followed for the time of four weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephan C Bischoff, University of Hohenheim
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2009
Primary Completion (Actual)
October 15, 2009
Study Completion (Actual)
October 15, 2009
Study Registration Dates
First Submitted
February 16, 2018
First Submitted That Met QC Criteria
February 16, 2018
First Posted (Actual)
February 23, 2018
Study Record Updates
Last Update Posted (Actual)
February 23, 2018
Last Update Submitted That Met QC Criteria
February 16, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fructose Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Diet
-
Laval UniversityDairy Farmers of Canada; Agriculture and Agri-Food CanadaCompleted
-
Tufts Medical CenterCompletedObesity | Cardiovascular Disease | Metabolic Syndrome
-
University of PittsburghCompletedCardiovascular Diseases | ObesityUnited States
-
Indiana University School of MedicineNational Institutes of Health (NIH)Completed
-
Hospital Parc Taulí, SabadellHospital Mutua de Terrassa; Consorci Sanitari de TerrassaTerminatedColorectal Cancer | Colon Adenoma | Colon PolypSpain
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Kaiser PermanenteNational Center for Complementary and Integrative Health (NCCIH)CompletedHypertension | ObesityUnited States
-
Pennington Biomedical Research CenterNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
Pennington Biomedical Research CenterThe Cleveland ClinicRecruiting
-
Oregon Health and Science UniversityCompletedTrifunctional Protein Deficiency | Carnitine Palmitoyltransferase 2 Deficiency | Very Long-chain Acyl-CoA Dehydrogenase Deficiency | Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency